13F HOLDINGS REPORT
OUP Management Co., LLC
Quarter ended Q4 2023 · Filed November 9, 2023 · Accession 0000950123-23-009816
Total Value
$44.5M
Positions
12
Other Managers
0
Confidential Omitted
No
Holdings (12)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Centessa Pharmaceuticals plc | CNTA | 2,937,615 | $19.0M | 42.74% |
| 2 | Aerovate Therapeutics Inc. | 008064107 | 603,762 | $8.2M | 18.43% |
| 3 | Cyteir Therapeutics, Inc. | 23284P103 | 2,459,572 | $7.0M | 15.71% |
| 4 | PMV Pharmaceuticals, Inc. | PMVP | 989,232 | $6.1M | 13.66% |
| 5 | Graphite Bio | 38870X104 | 406,308 | $1.0M | 2.27% |
| 6 | Selecta Biosciences, Inc. | 816212104 | 862,543 | $914,296 | 2.06% |
| 7 | Vor Biopharma Inc. | VOR | 374,714 | $794,394 | 1.79% |
| 8 | eFFECTOR Therapeutics, Inc. | 28202V108 | 1,025,697 | $615,316 | 1.38% |
| 9 | Precision BioSciences, Inc. | DTIL | 1,123,913 | $383,592 | 0.86% |
| 10 | Spero Therapeutics, Inc. | SPRO | 249,070 | $301,375 | 0.68% |
| 11 | Ikena Oncology, Inc. | 45175G108 | 26,833 | $116,187 | 0.26% |
| 12 | Homology Medicines, Inc. | 438083107 | 64,000 | $74,880 | 0.17% |